CUVL

Clinuvel Pharmaceuticals Limited

6.03 USD

Last updated Sep 12, 02:01 UTC

Yesterday HIGH

$6.08

Yesterday LOW

$5.8

52w HIGH

$8.2

52w LOW

$5.8

EPS

1.00

PE

6.03

Overview News Government Trades Fundamentals

Clinuvel Pharmaceuticals Limited stock is down -10.4% since 30 days ago. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 30.77% of the previous 22 September’s closed higher than August.

Avi Kapoor

Fri Aug 28, 2026

Marvell Technology, PayPal, Rubrik And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

U.S. stock futures mostly lower, Nasdaq 100 down 0.3%. Marvell Technology shares fall 7.6% after beating estimates, other stocks also drop in pre-market.
Benzinga Insights

Thu Aug 27, 2026

12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers Celularity (NASDAQ:CELU) stock moved upwards by 134.0% to $2.06 during Thursday's regular session. The company's market cap stands at $25.0 million. Propanc Biopharma (NASDAQ:PPCB) stock increased by
Benzinga Newsdesk

Thu Aug 27, 2026

Clinuvel Pharmaceuticals shares are trading lower after the company reported weak FY26 financial results.
Avi Kapoor

Thu Aug 27, 2026

HP, Best Buy Dollar Tree And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session

U.S. stock futures mixed, HP Inc shares fall in pre-market trading after beating earnings estimates and raising guidance. Other stocks also down.
Benzinga Insights

Thu Aug 27, 2026

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers VolitionRX (AMEX:VNRX) shares increased by 102.2% to $0.69 during Thursday's pre-market session. The company's market cap stands at $4.8 million. NewcelX (NASDAQ:NCEL) shares increased by 15.08% to
Benzinga Newsdesk

Thu Aug 27, 2026

CLINUVEL FY2026 Revenue Dips 1% To $94.0M From $95.0M, Cash Reserves Rise 12% To $252.1M Amid US Expansion Push

"CLINUVEL’s cash reserves following a decade of profitable operations give us financial independence in a period that has been challenging for many life science companies," said Mr Peter Vaughan, CLINUVEL’s
Benzinga Newsdesk

Thu Jul 23, 2026

CLINUVEL Announces US-Focused Restructuring With Headquarters Relocation And 10%-20% Workforce Reduction